Yali Liang
Biography
Yali Liang's latest research includes that Model-informed drug development (MIDD) is critical in all stages of the drug development process and almost all regulatory submissions for new agents incorporate some form of modeling and simulation
Research Interest
non-compartmental or compartmental PK data analysis and PK/PD modeling and simulation